Targets for renal carcinoma growth control identified by screening foxd1 cell proliferation pathways

HIGHLIGHTS

• who: Kyle H. Bond et al. from the Rogosin Institute, Room, East, th St, New York, NY, USA have published the paper: Targets for Renal Carcinoma Growth Control Identified by Screening FOXD1 Cell Proliferation Pathways, in the Journal: Cancers 2022, 14, 3958. of /2022/
• what: Using patient-derived tumor replicas, the authors demonstrate that the selected compounds perturb growth in multiple primary tumor lines. To identifying these factors as compounds of interest for further studies in tumor models, the analysis provides a foundation for a screening method that could be used to select candidate treatments . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.